• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Development and Validation of Distal Cholangiocarcinoma Early Recurrence (DICER) Score: Results from the US Extrahepatic Biliary Malignancy Consortium.

作者信息

Sahara Kota, Tsilimigras Diamantis I, Pawlik Timothy M

机构信息

Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan.

Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.

出版信息

Ann Surg Oncol. 2021 Aug;28(8):4214-4215. doi: 10.1245/s10434-021-09844-9. Epub 2021 Mar 21.

DOI:10.1245/s10434-021-09844-9
PMID:33748891
Abstract
摘要

相似文献

1
ASO Author Reflections: Development and Validation of Distal Cholangiocarcinoma Early Recurrence (DICER) Score: Results from the US Extrahepatic Biliary Malignancy Consortium.ASO作者反思：远端胆管癌早期复发（DICER）评分的开发与验证：美国肝外胆管恶性肿瘤联盟的结果
Ann Surg Oncol. 2021 Aug;28(8):4214-4215. doi: 10.1245/s10434-021-09844-9. Epub 2021 Mar 21.
2
ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.ASO作者反思：全身免疫炎症指数在肝外胆管癌切除术后是否是一个有用的生物标志物：来自美国肝外胆管恶性肿瘤联盟的结果。
Ann Surg Oncol. 2022 Nov;29(12):7615-7616. doi: 10.1245/s10434-022-12105-y. Epub 2022 Jul 1.
3
ASO Author Reflections: Bile Duct Resection-Is It Beneficial for Distal Cholangiocarcinoma?ASO作者反思：胆管切除术——对远端胆管癌有益吗？
Ann Surg Oncol. 2021 Apr;28(4):2000. doi: 10.1245/s10434-020-09171-5. Epub 2020 Oct 22.
4
Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.采用经十二指肠途径行左半肝切除术、尾状叶切除术及肝外胆管完全切除术治疗源于胆管乳头状瘤病的肝门部胆管癌。
J Surg Oncol. 2008 Aug 1;98(2):139-42. doi: 10.1002/jso.21089.
5
Extrahepatic cholangiocarcinoma: current surgical strategy.肝外胆管癌：当前的手术策略
Surg Oncol Clin N Am. 2009 Apr;18(2):269-88, viii. doi: 10.1016/j.soc.2008.12.003.
6
ASO Author Reflections: Is Major Hepatopancreatoduodenectomy Beneficial for Patients with Advanced and Widespread Extrahepatic Cholangiocarcinoma?ASO作者反思：扩大根治性肝胰十二指肠切除术对晚期广泛性肝外胆管癌患者有益吗？
Ann Surg Oncol. 2021 Apr;28(4):2026-2027. doi: 10.1245/s10434-020-09261-4. Epub 2020 Oct 21.
7
Preliminary study of the anatomy of the venous drainage of the intrahepatic and extrahepatic bile ducts and its relevance to the practice of hepatobiliary surgery.肝内和肝外胆管静脉引流的解剖学初步研究及其与肝胆外科手术实践的相关性。
ANZ J Surg. 2001 Jul;71(7):418-22. doi: 10.1046/j.1440-1622.2001.02150.x.
8
Early Recurrence Following Resection of Distal Cholangiocarcinoma: A New Tool for the Toolbox.远端胆管癌切除术后的早期复发：工具箱中的一种新工具。
Ann Surg Oncol. 2021 Aug;28(8):4069-4071. doi: 10.1245/s10434-021-09961-5. Epub 2021 Apr 8.
9
Surgical management of cholangiocarcinoma.胆管癌的外科治疗
Semin Liver Dis. 2004 May;24(2):189-99. doi: 10.1055/s-2004-828895.
10
CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.CD10+ 纤维母细胞在肝门部/肝外胆管癌的进展中比在周围型肝内胆管癌中更为活跃。
Histopathology. 2009 Oct;55(4):423-31. doi: 10.1111/j.1365-2559.2009.03398.x.

引用本文的文献

1
Development and validation of a gene expression-based nomogram to predict the prognosis of patients with cholangiocarcinoma.基于基因表达的列线图的开发和验证，以预测胆管癌患者的预后。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9577-9586. doi: 10.1007/s00432-023-04858-0. Epub 2023 May 24.
2
ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.ASO作者反思：全身免疫炎症指数在肝外胆管癌切除术后是否是一个有用的生物标志物：来自美国肝外胆管恶性肿瘤联盟的结果。
Ann Surg Oncol. 2022 Nov;29(12):7615-7616. doi: 10.1245/s10434-022-12105-y. Epub 2022 Jul 1.
3
Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.
肝外胆管癌切除术后全身免疫炎症指数的预后价值：美国肝外胆管恶性肿瘤联盟的研究结果
Ann Surg Oncol. 2022 Nov;29(12):7605-7614. doi: 10.1245/s10434-022-12058-2. Epub 2022 Jun 29.
4
Early Recurrence Following Resection of Distal Cholangiocarcinoma: A New Tool for the Toolbox.远端胆管癌切除术后的早期复发：工具箱中的一种新工具。
Ann Surg Oncol. 2021 Aug;28(8):4069-4071. doi: 10.1245/s10434-021-09961-5. Epub 2021 Apr 8.